Jairus Nandwa

Mr. Jairus Nandwa

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2023 in Journal of Molecular Structure
Verified
Journal Article
Closed access
MRMouhamed Z K A Raimi
Mouhamed Z K A Raimi
ANAneeqa Nadeem
Aneeqa Nadeem
KRKayode Raheem
Kayode Raheem
GHGhulam HUSSAIN
Ghulam HUSSAIN
NZNousheen Zafeer
Nousheen Zafeer
ASAsghar Shabbir
Asghar Shabbir

1 March 2025 in Current Pharmaceutical Analysis
Verified
Journal Article
Open access
HMHamadou Mamoudou
Hamadou Mamoudou
AAAboubakary Hamadou Abdoulaye
Aboubakary Hamadou Abdoulaye
NDNganso Yves Oscar Ditchou
Nganso Yves Oscar Ditchou
JNJairus Nandwa
Jairus Nandwa
RARaimi Mouhamed Zakiou Kolawole Adissa
Raimi Mouhamed Zakiou Kolawole Adissa
MMMartin Alain Mune Mune
Martin Alain Mune Mune

1 August 2024 in Intelligent Pharmacy
Verified
Journal Article
Open access
HAMADOU MAMOUDOUHAMADOU MAMOUDOU
HAMADOU MAMOUDOU
BBBahri Başaran
Bahri Başaran
MMMartin Alain Mune Mune
Martin Alain Mune Mune
AAAbdulhalim Musa Abubakar
Abdulhalim Musa Abubakar
JNJairus Nandwa
Jairus Nandwa
MHMuhammad Zaffar Hashmi
Muhammad Zaffar Hashmi

1 September 2024 in Non-coding RNA Research
Verified
Journal Article
Open access
JNJairus Nandwa
Jairus Nandwa
AMAzhar Mehmood
Azhar Mehmood
IMIshrat Mahjabeen
Ishrat Mahjabeen
KRKayode Yomi Raheem
Kayode Yomi Raheem
HAMADOU MAMOUDOUHAMADOU MAMOUDOU
HAMADOU MAMOUDOU
MKMahmood A. Kayani
Mahmood A. Kayani
AKT2 is crucial for cancer cells' invasion, metastasis, and survival. It is a possible downstream gene target of cancer glycolysis-related microRNAs. The study investigated the role of miRNA-4716–3p, rs2304186, and the AKT2 gene in blood cancer pathogenesis. RT-qPCR was used to analyze AKT2 gene mRNA and miRNA-4716–3p expression in 200 blood cancer samples and 200 healthy controls. Furthermore, Tetra-ARMS PCR was used to examine the rs2304186 AKT2 SNP in 300 patients and 290 control samples. miRNA-4716–3p was shown to be significantly downregulated (p = 0.0294), whereas mRNA expression of the AKT2 gene was found to be significantly upregulated (p = 0.0034) in blood cancer patients compared to healthy individuals. miRNA-4716–3p downregulation (p = 0.0466) was more pronounced, while AKT2 upregulation was non-significant (p = 0.1661) in untreated patients compared to chemotherapy-treated patients. Blood cancer risk was significantly associated with the rs2304186 GT genotype (p = 0.0432), TT genotype (p = 0.0502), and mutant allele (T) frequency (p = 0.0008). Polymorphism rs2304186 was associated with an increased risk of blood cancer in dominant (p = 0.0011), recessive (p = 0.0502), and additive (p = 0.0008) genetic models. The results suggested that the rs2304186 and the deregulated expression of miRNA-4716–3p and AKT2 gene at the mRNA level may significantly increase the incidence of blood cancer, particularly in the Pakistani population. Therefore, these may function as suitable biomarkers for blood cancer diagnosis and prognosis. Additional, larger-scale investigations may be required to affirm these results.

1 October 2025 in Current Proteomics
Verified
Journal Article
Open access
HAMADOU MAMOUDOUHAMADOU MAMOUDOU
HAMADOU MAMOUDOU
GNGaetan Bayiha Ba Njock
Gaetan Bayiha Ba Njock
AAAlbert Fouda Atangana
Albert Fouda Atangana
MKMc Jesus Kinyok
Mc Jesus Kinyok
JNJairus Nandwa
Jairus Nandwa
DPDieudonné Emmanuel Pegnyemb
Dieudonné Emmanuel Pegnyemb

1 January 2023 in Advances in Biomarker Sciences and Technology
Verified
Journal Article
Open access
KRKayode Raheem
Kayode Raheem
FIFawehinmi Praise Ibukunoluwa
Fawehinmi Praise Ibukunoluwa
SOSolomon Ayodele Olorundare
Solomon Ayodele Olorundare
JNJairus Nandwa
Jairus Nandwa
MAModinat Aina Abayomi
Modinat Aina Abayomi
FDFalana Taiwo Daniel
Falana Taiwo Daniel